With a $25 million grant from PCORI, the Penn team will launch a randomized controlled trial to see if their game reduces the ...

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...

Canada: Researchers have reported that a closed-loop insulin delivery system significantly improves glucose control during ...

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview Bristol-Myers Squibb ...

Turkey: A pilot study published in BMC Ophthalmology suggests that a gamified, app-based multimodal visual therapy may offer ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...

Patients with ABI require prolonged mechanical ventilation and have a substantially higher risk for VAP due to impaired airway protection and injury-related immune dysfunction. However, routine use of ...

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...